<DOC>
	<DOCNO>NCT00666354</DOCNO>
	<brief_summary>The purpose clinical study compare efficacy safety three concentration topical methotrexate treatment fingernail psoriasis .</brief_summary>
	<brief_title>Dose Response Safety Study Topical Methotrexate Treatment Fingernail Psoriasis</brief_title>
	<detailed_description>The purpose clinical study compare , control fashion , response three concentration methotrexate novel topical formulation treatment subject psoriasis fingernail . Such determination use basis evidence efficacy safety formulation therapeutic treatment fingernail psoriasis .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Diagnosed moderate fingernail psoriasis least two fingernail . Stable unchanged psoriasis therapy 2 month must receive methotrexate 3 month prior screen . Female patient 5 year post menopausal surgically sterile must use appropriate birth control specify time period negative pregnancy test . Target control fingernails thicker 2mm , abnormal infect ( bacterial fungal ) . Patients immunosuppression , HIV , neuropathy hand . Use methotrexate preparation , topical antipsoriatic medication ultraviolet treatment within 2 month study visit 1 . Use one 2week course oral corticosteroid therapy one injection 3 month prior screen visit . Use manicure cosmetic nail product within 7 day start treatment . Use drug know potential toxicity major organ within 90 day prior start treatment . Patients nurse , pregnant plan become pregnant father child within study time frame include within three month last dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Nail Psoriasis</keyword>
	<keyword>Psoriasis</keyword>
	<keyword>Fingernail Psoriasis</keyword>
	<keyword>Methotrexate</keyword>
</DOC>